Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,275 | -68,683 | -31,054 | -101,252 | -73,820 |
| Depreciation Amortization | 1,476 | 936 | 369 | 1,765 | 1,400 |
| Accounts receivable | 695 | 691 | -709 | 1,824 | 2,723 |
| Accounts payable and accrued liabilities | N/A | 2,579 | N/A | N/A | 3,947 |
| Other Working Capital | 11,100 | 6,900 | 776 | -3,530 | -3,838 |
| Other Operating Activity | 13,868 | 6,078 | 3,620 | 8,628 | 1,008 |
| Operating Cash Flow | $-79,136 | $-51,499 | $-26,998 | $-92,565 | $-68,580 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,936 | 38,339 | 15,974 | 5,134 | 8,197 |
| PPE Investments | -263 | -180 | -93 | -366 | -262 |
| Investing Cash Flow | $61,673 | $38,159 | $15,881 | $4,768 | $7,935 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,477 | 19,477 | 19,477 | 10,353 | 10,353 |
| Debt Repayment | N/A | N/A | N/A | -4,025 | -4,025 |
| Common Stock Issued | 1,161 | 977 | 563 | 56,252 | 54,895 |
| Other Financing Activity | 0 | 0 | 0 | -76 | -56 |
| Financing Cash Flow | $20,638 | $20,454 | $20,040 | $62,504 | $61,167 |
| Beginning Cash Position | 28,275 | 28,275 | 28,275 | 53,568 | 53,568 |
| End Cash Position | 31,450 | 35,389 | 37,198 | 28,275 | 54,090 |
| Net Cash Flow | $3,175 | $7,114 | $8,923 | $-25,293 | $522 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,136 | -51,499 | -26,998 | -92,565 | -68,580 |
| Capital Expenditure | -263 | -180 | -93 | -366 | -262 |
| Free Cash Flow | -79,399 | -51,679 | -27,091 | -92,931 | -68,842 |